To include your compound in the COVID-19 Resource Center, submit it here.

RSD1235: Phase III

COM began the placebo-controlled Phase III ACT 1

Read the full 89 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE